[ad_1]
India broke barrier of 27 million covid-19 infections on Wednesday since the virus began to be detected in the country, in a day when the number of deaths has risen to more than 4,000 per day and the positives have seen a slight increase.
The number of cases rose to 208,921 after falling below the 200,000 threshold yesterday for the first time in 41 days, bringing the total since the start of the pandemic to 27 million, data that only exceeds the United States, with just over 33 million, according to the Indian Ministry of Health.
The downward trend in positives contrasts with the death rate, which added 4,157 new deaths after yesterday’s data dropped by nearly a thousand and which totaled 311,388, remaining the third most affected country, only behind the United States and Brazil.
The Asian country has also reported a record number of PCR tests for SARS-CoV-2, with more than 2.2 million tests performed in the past 24 hours.
The western state of Maharashtra, the most affected by the virulence of this second wave, again concentrated 25% of the deaths due to the covidus recorded in the country after having exceeded the thousand deaths, while the rate of cases remains below 30,000 a day.
Meanwhile, New Delhi continues to show signs of recovery, reporting 156 deaths and 1,568 infections in the past 24 hours that take it away from the reality it experienced weeks ago, with images of overcrowded crematoriums , queues near hospitals and severe oxygen shortages. doctor.
VACCINATION
The vaccination campaign reached 200 million vaccinations after giving just over two million doses on the last day.
Thus, more than 43.4 million beneficiaries have already received the two doses of Covishield from AstraZeneca, which is manufactured by the Serum Institute of India (SII); Covaxin, from the Indian laboratory Bharat Biotech; or the Russian vaccine Sputnik V.
However, these data do not guarantee the initial target set by the Indian authorities to vaccinate 300 million people by July.
This country of 1350 million inhabitants began on May 1 the vaccination of the population group between 18 and 44 years. However, several regions reported serious problems starting this new phase due to the lack of doses.
(With EFE information)
KEEP READING:
[ad_2]
Source link